Pharmacokinetics and Pharmacogenetics of Dabigatran
Dabigatran etexilate is a prodrug of dabigatran, a oral direct inhibitor of thrombin. Pharmacokinetics of dabigatran etexilate doesn’t have the disadvantages of vitamin K antagonists. However, pharmacokinetics and pharmacogenetics of dabigatran are variable. This can affect both effectiveness and sa...
| Published in: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2021-03-01
|
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2400 |